See All Slides - tctmd.com

Slides

Presentation TCT 2013

Update on ADSCs and MPCs for STEMI

Presenter: Henricus Duckers

October 29, 2013

$Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO$

Presentation TCT 2013

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Presenter: Timothy Henry

October 29, 2013

Presentation TCT 2013

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Presenter: Nils Johnson

October 29, 2013

Presentation

Outcome Data for Devices-Based Repair

Presenter: Ted Feldman

October 29, 2013

Presentation TCT 2013

TAVI Valve-in-Valve for Failing Stentless Valves: Technical Tips and Clinical Outcomes

Presenter: Neil Moat

October 29, 2013

Presentation TCT 2013

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

Presenter: Robert Bonow

October 29, 2013

Presentation TCT 2013

The Imaging Revolution Will Forever Change the Approach to Coronary Artery Disease

Presenter: Stephan Achenbach

October 29, 2013

Presentation TCT 2013

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

Presenter: Byoung Kwon Lee

October 29, 2013

Presentation TCT 2013

TCT-68. Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study

Presenter: Bernhard Witzenbichler

October 29, 2013

Presentation TCT 2013

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

Presenter: JM White

October 29, 2013

Advertisement

Slides

Update on ADSCs and MPCs for STEMI

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Outcome Data for Devices-Based Repair

TAVI Valve-in-Valve for Failing Stentless Valves: Technical Tips and Clinical Outcomes

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

The Imaging Revolution Will Forever Change the Approach to Coronary Artery Disease

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

TCT-68. Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content